GB2127823B - Quinazolines - Google Patents

Quinazolines

Info

Publication number
GB2127823B
GB2127823B GB08326030A GB8326030A GB2127823B GB 2127823 B GB2127823 B GB 2127823B GB 08326030 A GB08326030 A GB 08326030A GB 8326030 A GB8326030 A GB 8326030A GB 2127823 B GB2127823 B GB 2127823B
Authority
GB
United Kingdom
Prior art keywords
quinazolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08326030A
Other languages
English (en)
Other versions
GB8326030D0 (en
GB2127823A (en
Inventor
Victor T Bandurco
Seymour D Levine
Dennis M Mulvey
Alfonso J Tobia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of GB8326030D0 publication Critical patent/GB8326030D0/en
Publication of GB2127823A publication Critical patent/GB2127823A/en
Application granted granted Critical
Publication of GB2127823B publication Critical patent/GB2127823B/en
Priority to SG31787A priority Critical patent/SG31787G/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C07C265/12—Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08326030A 1982-09-30 1983-09-29 Quinazolines Expired GB2127823B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG31787A SG31787G (en) 1982-09-30 1987-03-31 Substituted quinzolinones having functionality at n1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/430,552 US4490374A (en) 1982-09-30 1982-09-30 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use
JP59058527A JPS60204770A (ja) 1982-09-30 1984-03-28 ジヒドロキシ−２（１ｈ）キナゾリノン−１−アルカン酸類

Publications (3)

Publication Number Publication Date
GB8326030D0 GB8326030D0 (en) 1983-11-02
GB2127823A GB2127823A (en) 1984-04-18
GB2127823B true GB2127823B (en) 1987-01-07

Family

ID=26399581

Family Applications (2)

Application Number Title Priority Date Filing Date
GB08326030A Expired GB2127823B (en) 1982-09-30 1983-09-29 Quinazolines
GB08519309A Expired GB2163426B (en) 1982-09-30 1985-07-31 Substituted quinazolinones having functionality at n1

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08519309A Expired GB2163426B (en) 1982-09-30 1985-07-31 Substituted quinazolinones having functionality at n1

Country Status (14)

Country Link
US (1) US4490374A (de)
EP (2) EP0107398B1 (de)
JP (2) JPS5982374A (de)
AU (1) AU563958B2 (de)
CA (1) CA1215712A (de)
DK (1) DK159311C (de)
FI (1) FI833523A (de)
GB (2) GB2127823B (de)
GR (1) GR79366B (de)
HK (2) HK98787A (de)
IE (1) IE56413B1 (de)
PT (1) PT77422B (de)
SU (2) SU1407398A3 (de)
ZA (1) ZA837302B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656267A (en) * 1983-09-29 1987-04-07 Ortho Pharmaceutical Corporation Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters
US4556739A (en) * 1983-09-29 1985-12-03 Ortho Pharmaceutical Corporation 3,4-Dialkoxy-2-alkylcarbonyl analino compounds
US4617392A (en) * 1983-09-29 1986-10-14 Ortho Pharmaceutical Corporation 4-alkyl-5,6-methylenedioxy-2-1[H]-quinazolinones useful as cardiotonic agents
US4731480A (en) 1985-07-29 1988-03-15 Ortho Pharmaceutical Corporation Process for preparing 2-acyl-3,4-dialkoxyanilines
KR900003529B1 (ko) 1985-07-29 1990-05-21 오르토 파마슈티컬 코포레이션 2-아실-3,4-디알콕시아닐린의 제조방법
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US4975428A (en) * 1988-05-31 1990-12-04 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) * 1991-08-16 1993-03-16 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
US7780628B1 (en) 1999-01-11 2010-08-24 Angiodynamics, Inc. Apparatus and methods for treating congestive heart disease
US7329236B2 (en) 1999-01-11 2008-02-12 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US7481803B2 (en) 2000-11-28 2009-01-27 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US6749598B1 (en) 1999-01-11 2004-06-15 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
BR0015718A (pt) * 1999-11-22 2002-07-23 Warner Lambert Co Quinazolinas e seu uso para inibição de enzimas de cinase dependente de ciclina
US6982260B1 (en) 1999-11-22 2006-01-03 Warner-Lambert Company Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
US7063679B2 (en) 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
US20050197624A1 (en) 2004-03-04 2005-09-08 Flowmedica, Inc. Sheath for use in peripheral interventions
EP1585572A4 (de) 2002-09-20 2010-02-24 Flowmedica Inc Verfahren und vorrichtung zur intraaortalen wirkstoffabgabe an eine gefässverzweigung
AU2003300779A1 (en) 2002-09-20 2004-05-04 Flowmedica, Inc. Catheter system for renal therapy
JP2006508776A (ja) 2002-09-20 2006-03-16 フローメディカ，インコーポレイテッド 腎臓内カテーテルを介する選択的物質送達のための方法および装置
US7993325B2 (en) 2002-09-20 2011-08-09 Angio Dynamics, Inc. Renal infusion systems and methods
EP1635736A2 (de) 2003-06-05 2006-03-22 FlowMedica, Inc. Systeme und verfahren zur durchführung von bilateralen interventionen oder diagnose in verzweigten körperlumen
WO2005112980A2 (en) 2004-05-14 2005-12-01 Flowmedica, Inc. Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy
US7771401B2 (en) 2006-06-08 2010-08-10 Angiodynamics, Inc. Selective renal cannulation and infusion systems and methods
KR101691954B1 (ko) 2016-04-26 2017-01-02 고려대학교 산학협력단 신규 n-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1280551A (en) * 1968-07-01 1972-07-05 Sandoz Ltd Quinazoline derivatives
US3950526A (en) * 1970-04-20 1976-04-13 Sumitomo Chemical Company, Limited Quinazoline derivatives in pharmaceutical compositions for treating pain and inflammation
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3859237A (en) * 1970-04-20 1975-01-07 Sumitomo Chemical Co Quinazoline derivatives
SE392616B (sv) * 1971-06-29 1977-04-04 Sumitomo Chemical Co Forfarande for framstellning av kinazolinonforeningar
JPS4887012A (de) * 1972-02-21 1973-11-16
JPS5013271B2 (de) * 1971-10-04 1975-05-19
JPS4948957B2 (de) * 1971-10-26 1974-12-24
JPS555506B2 (de) * 1972-09-07 1980-02-07
JPS5217842A (en) * 1975-07-31 1977-02-10 Canon Inc Device for fabricating sound hologram
ZA796623B (en) * 1978-12-07 1981-07-29 Ortho Pharma Corp Substituted pyrrolo (1,2-c) quinazolines
AU533427B2 (en) * 1978-12-07 1983-11-24 Ortho Pharmaceutical Corporation Substituted 2(1h) quinazolinones
GB2039895B (en) * 1978-12-07 1983-03-02 Ortho Pharma Corp 4-substituted-2(1h)quinazolinones

Also Published As

Publication number Publication date
GB2163426B (en) 1987-01-07
IE56413B1 (en) 1991-07-31
DK449183D0 (da) 1983-09-29
FI833523A (fi) 1984-03-31
SU1344246A3 (ru) 1987-10-07
EP0220786A2 (de) 1987-05-06
GB8519309D0 (en) 1985-09-04
GB8326030D0 (en) 1983-11-02
FI833523A0 (fi) 1983-09-29
EP0107398B1 (de) 1988-06-08
DK449183A (da) 1984-03-31
SU1407398A3 (ru) 1988-06-30
AU563958B2 (en) 1987-07-30
IE832307L (en) 1984-03-30
PT77422B (en) 1986-09-10
HK98887A (en) 1987-12-31
DK159311B (da) 1990-10-01
PT77422A (en) 1983-10-01
ZA837302B (en) 1985-05-29
CA1215712A (en) 1986-12-23
EP0220786B1 (de) 1990-11-22
GB2163426A (en) 1986-02-26
GR79366B (de) 1984-10-22
DK159311C (da) 1991-03-11
US4490374A (en) 1984-12-25
EP0220786A3 (en) 1988-02-24
EP0107398A1 (de) 1984-05-02
HK98787A (en) 1987-12-31
JPS60204770A (ja) 1985-10-16
AU1979483A (en) 1984-04-05
GB2127823A (en) 1984-04-18
JPS5982374A (ja) 1984-05-12

Similar Documents

Publication Publication Date Title
GB2127823B (en) Quinazolines
DE3377726D1 (en) Roofing
PH19011A (en) Quinazoline derivatives
AR242637A1 (es) Zurradera (maquina de zurrar) para el procesamiento de cueros y pieles.
GB8405676D0 (en) Quinazolines
CA50493S (en) Shingle
CA50494S (en) Shingle
GB2127809B (en) Certain b-oxo-a-carbamoyl-pyrrolepropionitriles
ZA832701B (en) Imidazoquinoxalines
GB8306360D0 (en) Quinazolines
GB2128216B (en) Guttering
ZA832792B (en) Quinazoline derivatives
IE870548L (en) Quinazolinones
CS1010682A1 (en) Samosvorny hydraulicky obvod
IE831100L (en) Quinazolines
CA50163S (en) Skillet-oven
CA50660S (en) Gamesboard
CA50080S (en) Bruach
AU88512S (en) Section
AU87407S (en) Section
IE822826L (en) Gutters
PL239447A2 (en) Feeding-measuring set
ZA821688B (en) Roofing
AU89092S (en) Aquabike
BG45685A1 (en) Rc- generator

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920929